Structural pituitary abnormalities associated with CHARGE syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages

  Gregory, Louise C ^a   Gevers, Evelien F ^b   Baker, Joanne ^c   Kasia, Tessa ^a   Chong, Kling ^b   Josifova, Dragana J ^d   Caimari, Maria ^e   Bilan, Frederic ^f   McCabe, Mark J ^a   Dattani, Mehul T ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c KENT AND CANTERBURY HOSPITAL   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

^e HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^f POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; FOLLITROPIN; GROWTH HORMONE; HYDROCORTISONE; LUTEINIZING HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN; THYROXINE;

ADRENOCORTICOTROPIC HORMONE DEFICIENCY; ARTICLE; BIRTH WEIGHT; BRAIN DEVELOPMENT; BRAIN MALFORMATION; CASE REPORT; CHD7 GENE; COLOBOMA; CORPUS CALLOSUM; CRYPTORCHISM; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; EAR MALFORMATION; ECTOPIC POSTERIOR PITUITARY; FALLOT TETRALOGY; FOLLICLE STIMULATING HORMONE DEFICIENCY; GENE; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GROWTH HORMONE DEFICIENCY; HETEROZYGOSITY; HORMONAL THERAPY; HORMONE DEFICIENCY; HUMAN; HYPERMETROPIA; HYPOPHYSIS DISEASE; HYPOPITUITARISM; HYPOTHYROIDISM; INTRON; LUTEINIZING HORMONE DEFICIENCY; MALE; MENINGOCELE; MICROPENIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; PERCEPTION DEAFNESS; PITUITARY STALK; PRIORITY JOURNAL; SEPTOOPTIC DYSPLASIA; SEPTUM PELLUCIDUM; SYNDROME CHARGE; TESTOSTERONE BLOOD LEVEL; THYROID STIMULATING HORMONE DEFICIENCY; TUBER CINEREUM;

AMINO ACID SEQUENCE; BASE SEQUENCE; CHARGE SYNDROME; CHILD; COHORT STUDIES; CONSENSUS SEQUENCE; DNA HELICASES; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; HUMANS; HYPOPITUITARISM; MALE; MODELS, BIOLOGICAL; PITUITARY GLAND; SEPTO-OPTIC DYSPLASIA;

SIA;

EID: 84876273989     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3467     Document Type: Article

References (27)

1. Zentner GE, Layman WS, Martin D.M., Scacheri PC Molecular and phenotypicaspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A. 2010; 152A:674-686.
2. Issekutz KA, Graham JM Jr, Prasad C, Smith IM, Blake KD An epi-demiological analysis of CHARGE syndrome: preliminary results from a Canadian study. Am J Med Genet A. 2005; 133A:309-317.
3. Jongmans MC, Admiraal RJ, van der Donk KP, et al. CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet. 2006; 43:306-314.
4. Lalani SR, Safiullah AM, Molinari L.M., Fernbach SD, Martin DM, Belmont JW SEMA3E mutation in a patient with CHARGE syndrome. J Med Genet. 2004; 41(7):e94.
5. Schnetz MP, Bartels CF, Shastri K, et al Genomic distribution of CHD7 on chromatin tracks of H3K4 methylation patterns. Genome Res. 2009; 19:590-601.
6. Kim HG, Layman LC The role of CHD7 and the newly identified WDR11 gene in patients with idiopathic hypogonadotrophic hypo-gonadism and Kallmann syndrome. Mol Cell Endocrinol. 2011; 346(1-2):74-83.
7. Layman WS, Hurd EA, Martin DM Chromodomain proteins in development: lessons from CHARGE syndrome. Clin Genet. 2010; 78(1):11-20.
8. Hurd EA, Capers PL, Blauwkamp M.N., et al Loss of Chd7 function in gene-trapped reporter mice is embryonic lethal and associated with severe defects in multiple developing tissues. Mamm Genome. 2007; 18(2):94-104.
9. Jongmans MC, Hoefsloot LH, van der Donk KP, et al. Familial CHARGE syndrome and the CHD7 gene: a recurrent missense mutation, intrafamilial recurrence and variability. Am J Med Genet A. 2008; 146A(1):43-50.
10. Sanlavile D, Etchevers HC, Gonzales M, et al Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J Med Gen. 2006; 43(3):211-217.
11. Layman WS, Hurd EA, Martin DM Reproductive dysfunction and decreased GnRH neurogenesis in a mouse model of CHARGE syndrome. Hum Mol Genet. 2011; 20(16):3138-3150.
12. Kim HG, Kurth I, Lan F., et al Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet. 2008; 83(4):511-519.
13. Schnetz MP, Handoko L, Akhtar-Zaidi B, et al CHD7 targets active gene enhancer elements to modulate ES cell-specific geneexpression. PLoS Genet. 2010; 6(7):e1001023.
14. Engelen E, Akinci U, Bryne J.C., et al Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. Nat Genet. 2011; 43(6):607-611.
15. Williamson KA, Hever AM, Rainger J, et al Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome. Hum Mol Genet. 2006; 15(9):1413-1422.
16. Kelberman D, Rizzoti K, Avilion A., et al Mutations within Sox2/ SOX2 are associated with abnormalities in the hypothalamo-pitu-itary-gonadal axis in mice and humans. J Clin Invest. 2006; 116(9): 2442-2455.
17. McCabe MJ, Alatzoglou KS, Dattani MT Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond. Best Pract Res Clin Endocrinol Metab. 2011; 25(1):115-124.
18. Reynaud R, Jayakody SA, Monnier C, et al PROKR2 variants in multiple hypopituitarism with pituitary stalk interruption. J Clin Endocrinol Metab. 2012; 97(6):E1068-E1073.
19. Pinto G, Abadie V, Mesnage R., et al CHARGE syndrome includes hypogonadotropic hypogonadism and abnormal olfactory bulb development. J Clin Endocrinol Metab. 2005; 90(10):5621-5626.
20. James PA, Aftimos S, Hofman P. CHARGE association and secondary hypoadrenalism. Am J Med Genet A. 2003; 117A(2):177-180.
21. Asakura Y, Toyota Y, Muroya K., et al Endocrine and radiological studiesinpatients with molecularly confirmed CHARGE syndrome. J Clin Endocrinol Metab. 2008; 93(3):920-924.
22. França M.M., Jorge AA, Carvalho L.R., et al Novel heterozygous nonsense GLI2 mutations in patients with hypopituitarism and ec-topic posterior pituitary lobe without holoprosencephaly. J Clin Endocrinol Metab. 2010; 95(11):E384-E391.
23. Jayakody S, Andoniadou CL, Gaston-Massuet C, et al SOX2 regulates the hypothalamic-pituitary axis at multiple levels. J Clin Invest. 2012; 122(10):3635-3646.
24. Layman WS, McEwen DP, Beyer L.A., et al Defectsinneural stemcell proliferation and olfaction in Chd7 deficient mice indicate a mechanism for hyposmia in human CHARGE syndrome. Hum Mol Genet. 2009; 18(11):1909-1923.
25. Bergman JE, deRonde W, Jongmans M.C., et al The results of CHD7 analysis in clinically well-characterized patients with Kallmann syndrome. J Clin Endocrinol Metab. 2012; 97(5):E858-E862.
26. Kelberman D, Rizzoti K, Lovell-Badge R, Robinson I.C., Dattani MT Genetic regulation of pituitary gland development in human and mouse. Endocr Rev. 2009; 30(7):790-829.
27. Lalani SR, Safiulla AM, Fernback S.D., et al Spectrum of CHD7 mutations in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am J Hum Genet. 2006; 78(2):303-314.